These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 14633123)

  • 1. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
    Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
    Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
    J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
    Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
    Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms and therapeutic strategies of chronic renal injury: role of rho-kinase in the development of renal injury.
    Hayashi K; Wakino S; Kanda T; Homma K; Sugano N; Saruta T
    J Pharmacol Sci; 2006 Jan; 100(1):29-33. PubMed ID: 16397371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats.
    Nishikimi T; Akimoto K; Wang X; Mori Y; Tadokoro K; Ishikawa Y; Shimokawa H; Ono H; Matsuoka H
    J Hypertens; 2004 Sep; 22(9):1787-96. PubMed ID: 15311108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.
    Sun GP; Kohno M; Guo P; Nagai Y; Miyata K; Fan YY; Kimura S; Kiyomoto H; Ohmori K; Li DT; Abe Y; Nishiyama A
    J Am Soc Nephrol; 2006 Aug; 17(8):2193-201. PubMed ID: 16790507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.
    Tsounapi P; Saito M; Kitatani K; Dimitriadis F; Ohmasa F; Shimizu S; Kinoshita Y; Takenaka A; Satoh K
    Eur J Pharmacol; 2012 Sep; 691(1-3):182-9. PubMed ID: 22819709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rho-kinase inhibitor, fasudil, attenuates progressive glomerulosclerosis induced by daunorubicin in rats.
    Deng B; Yang X; Zhu Z; Zhang C
    J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):720-4. PubMed ID: 20037814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Rho-kinase and p27 in angiotensin II-induced vascular injury.
    Kanda T; Hayashi K; Wakino S; Homma K; Yoshioka K; Hasegawa K; Sugano N; Tatematsu S; Takamatsu I; Mitsuhashi T; Saruta T
    Hypertension; 2005 Apr; 45(4):724-9. PubMed ID: 15699465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of rho-kinase inhibitor on cardiac hypertrophy of left ventricle in spontaneously hypertensive rats].
    Zhang ZJ; Fan YF; Zhang ZY; Xie PY; Fang HC; Su YS
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3438-41. PubMed ID: 23327708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway.
    Song J; Kost CK; Martin DS
    Cardiovasc Res; 2006 Dec; 72(3):456-63. PubMed ID: 17049502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
    Behuliak M; Vavřínová A; Bencze M; Polgárová K; Ergang P; Kuneš J; Vaněčková I; Zicha J
    J Hypertens; 2015 Dec; 33(12):2443-54. PubMed ID: 26418671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tight blood pressure control decreases apoptosis during renal damage.
    Soto K; Gómez-Garre D; Largo R; Gallego-Delgado J; Tejera N; Catalán MP; Ortiz A; Plaza JJ; Alonso C; Egido J
    Kidney Int; 2004 Mar; 65(3):811-22. PubMed ID: 14871401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
    Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
    Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis.
    Nishikimi T; Matsuoka H
    J Pharmacol Sci; 2006 Jan; 100(1):22-8. PubMed ID: 16397372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.